v3.26.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 429,376 $ 79,148
Short-term investment securities 75,295 62,822
Accounts receivable, net 416,821 305,628
Inventories 194,319 125,586
Other current assets 55,636 57,580
Total current assets 1,171,447 630,764
Restricted cash 1,375 1,342
Long-term investment securities 56,035 59,136
Right of use assets 6,830 6,278
Deferred tax assets 333,383 348,000
Non-current inventories 20,806 15,689
Other noncurrent assets 2,376 2,044
Total assets 1,592,252 1,063,253
Current liabilities:    
Accounts payable and accrued expenses 176,859 107,508
Other current liabilities 1,222 2,124
Lease liability – current portion 1,844 1,044
Deferred revenue - current portion 26,102 21,234
Accrued compensation 54,499 21,850
Total current liabilities 260,526 153,760
Deferred revenue, non-current portion 7,070 8,807
Loan payable – non-current 745,634 245,645
Lease liability – non-current 6,895 7,021
Total liabilities 1,020,125 415,233
Commitments and contingencies
Stockholders’ equity:    
Common stock, $0.001 par value per share (190,000,000 and 190,000,000 shares authorized, 160,054,603 and 158,849,596 shares issued, 151,159,605 and 155,305,953 shares outstanding at September 30, 2026 and December 31, 2025, respectively) 160 159
Additional paid-in capital 1,871,185 1,830,110
Treasury stock, at cost, 8,894,998 and 3,543,643 shares at September 30, 2026 and December 31, 2025, respectively (300,224) (100,234)
Accumulated deficit (998,994) (1,082,015)
Total stockholders’ equity 572,127 648,020
Total liabilities and stockholders’ equity $ 1,592,252 $ 1,063,253